{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:50:52Z","timestamp":1777056652513,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>\n                    The potential causal relationship between autoimmune diseases (AIDs) and breast cancer (BC) remains a topic of debate. In this study, we conducted Mendelian randomization (MR) analysis between common AIDs and BC using publicly available genome-wide association studies data from the MR Base platform. Initially, we conducted a two-sample MR analysis of 10 AIDs and BC using the inverse variance weighted method. Subsequently, a series of sensitivity analyses were performed to validate the robustness of our findings. Lastly, we utilized the reverse MR analysis to evaluate the potential for reverse causality. Among the 10 types of AID studied, 3 were found to be associated with an elevated risk of BC. These include ankylosing spondylitis (odds ratio [OR]: 1.21; 95% confidence interval [CI]: 1.04\u20131.41;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.013), inflammatory bowel disease (OR: 1.05; 95% CI: 1.01\u20131.09;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.012), and rheumatoid arthritis (OR: 1.04; 95% CI: 1.01\u20131.07;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.023). Additionally, BC was found to be linked with a heightened risk of inflammatory bowel disease (OR: 1.112; 95% CI: 1.022\u20131.210;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.014). Our study\u2019s findings support a bidirectional causal relationship between AIDs and BC, offering novel insights into the developmental mechanisms underlying the interaction between AIDs and BC.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045283","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:00:24Z","timestamp":1763154024000},"page":"e45283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Causal association between autoimmune diseases and risk of breast cancer: A bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-2504","authenticated-orcid":false,"given":"Luyao","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danxiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qikuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xujun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China"},{"name":"Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2024.09.008","article-title":"Immunomodulatory metal-based biomaterials for cancer immunotherapy.","volume":"375","author":"Yuan","year":"2024","journal-title":"J Control Release"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus.","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/1756-185X.13655","article-title":"Incidence and patterns of malignancies in a multi-ethnic cohort of rheumatoid arthritis patients.","volume":"22","author":"Lim","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14309\/ajg.0000000000002168","article-title":"Surveillance for colorectal neoplasia in inflammatory bowel disease: when to stop.","volume":"118","author":"Axelrad","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jare.2023.07.003","article-title":"Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: implications from the global burden of disease study 2019.","volume":"59","author":"Wu","year":"2024","journal-title":"J Adv Res"},{"key":"R6-20251121","first-page":"158","article-title":"Breast cancer and the immune system.","volume":"6","author":"Standish","year":"2008","journal-title":"J Soc Integr Oncol"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/aje\/kwm165","article-title":"The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.","volume":"166","author":"Fewell","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"1229570","DOI":"10.3389\/fimmu.2023.1229570","article-title":"Influence of genetically predicted autoimmune diseases on NAFLD.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/annrheumdis-2019-216747","article-title":"Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study.","volume":"81","author":"Lee","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.42239","article-title":"Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk.","volume":"74","author":"Yuan","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12916-022-02578-9","article-title":"Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study.","volume":"20","author":"Alipour","year":"2022","journal-title":"BMC Med"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"e34612","DOI":"10.1097\/MD.0000000000034612","article-title":"Investigation of the causal relationship between breast cancer and autoimmune diseases: a bidirectional Mendelian randomization study.","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.14036","article-title":"Cancer diagnosis and mortality in patients with ankylosing spondylitis: a Western Australian retrospective cohort study.","volume":"24","author":"Kelty","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/1756-185X.14658","article-title":"Ankylosing spondylitis shares a common therapeutic target with breast cancer.","volume":"26","author":"Feng","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CEJ.0000000000000667","article-title":"Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies.","volume":"31","author":"Gong","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1245\/s10434-014-4198-0","article-title":"Hospitalization for inflammatory bowel disease is associated with increased risk of breast cancer: a nationwide cohort study of an Asian population.","volume":"22","author":"Tsai","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ol.2020.11981","article-title":"Identification of key pathways and genes shared between Crohn\u2019s disease and breast cancer using bioinformatics analysis.","volume":"20","author":"Zhou","year":"2020","journal-title":"Oncol Lett"},{"key":"R22-20251121","first-page":"571","article-title":"Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study.","volume":"11","author":"Hovde","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1002\/cam4.5989","article-title":"Survival in elderly patients with breast cancer with and without autoimmune disease.","volume":"12","author":"Dedousis","year":"2023","journal-title":"Cancer Med"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"rjad160","DOI":"10.1093\/jscr\/rjad160","article-title":"An unwelcome guest: two cases of colonic metastatic lobular breast cancer.","volume":"2023","author":"Naresh","year":"2023","journal-title":"J Surg Case Rep"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"453012","DOI":"10.1155\/2014\/453012","article-title":"Breast cancer risk in rheumatoid arthritis: an update meta-analysis.","volume":"2014","author":"Tian","year":"2014","journal-title":"Biomed Res Int"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.30134","article-title":"The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan.","volume":"63","author":"Chen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R28-20251121","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis.","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"R29-20251121","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"R30-20251121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders \u2013 what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"R31-20251121","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R32-20251121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","article-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.","volume":"62","author":"Monach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R33-20251121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41420-024-02077-1","article-title":"Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions.","volume":"10","author":"Zhong","year":"2024","journal-title":"Cell Death Discov"},{"key":"R34-20251121","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.autrev.2018.01.003","article-title":"Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors.","volume":"17","author":"Lidar","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R35-20251121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy.","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat Rev Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:01:27Z","timestamp":1763766087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":35,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045283","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-05-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}